期刊文献+

血管生成抑制蛋白1与肿瘤血管及内镜下的表现关系分析 被引量:4

Analysis of the relationship between the expression of angiogenesis inhibitor 1 in tumor vessel and endoscopic manifestations
下载PDF
导出
摘要 目的:探讨血管生成抑制蛋白1(VASH1)在食管癌肿瘤血管中的表达与内镜下表现的关系。方法:选取存档石蜡包埋食管癌组织标本120例和正常食管组织标本50例,免疫组织化学SP法检测其VASH1的表达,分析VASH1在食管癌组织和正常食管组织中的形态差异,分析不同IPCL分型VASH1表达情况,以及不同肿瘤分化状态下VASH1表达与MVD的关系。结果:VASH1、血管内皮生长因子(VEGF)在食管癌组织中的阳性表达率分别为54. 17%(65/120)、59. 17%(71/120),在正常组织中的阳性表达率分别为8. 0%(4/50)、16. 0%(8/50),VASH1、VEGF在食管癌组织中的阳性表达率高于正常组织(P <0. 01);食管癌组织中,VEGF与VASH1表达呈显著正相关关系,影响食管癌预后效果的独立危险因素有浸润深度、淋巴结转移、VASH1及VEGF表达水平等(P <0. 05~P <0. 01);上皮乳头内毛细血管襻Ⅴ型病人占比最高为54. 79%,Ⅳ型为56. 82%,差异无统计学意义(P> 0. 05); VASH1阴性、低表达、高表达病人的MVD值差异有统计学意义(P <0. 01),随着VASH1表达增加,病人MVD值增高,VASH1表达与血管形成呈正相关关系(P <0. 01)。结论:VASH1可能与食管癌的发展、肿瘤细胞生成密切相关,且对预测食管癌的预后具有一定的意义。 Objective: To investigate the relationship between the expression of angiogenesis inhibitor 1( VASH1) and endoscopic manifestations in esophageal carcinoma. Methods: The expression levels of VASH1 in 120 paraffin embedded esophageal carcinoma samples and 50 normal esophageal tissues samples were detected using immunohistochemical SP method. The expression difference of VASH1 between esophageal carcinoma and normal esophageal tissue was analyzed. The expression levels of VASH1 in different IPCL types,and relationship between VASH1 expression and MVD in different differentiation tumors were analyzed. Results: The positive expression rates of VASH1 and VEGF in esophageal carcinoma were 54. 17%( 65/120) and 59. 17%( 71/120),respectively,and the positive expression rates of VASH1 and VEGF in normal VASH1 tissue were 8. 0%( 4/50) and 16. 0%( 8/50),respectively. The positive rates of VASH1 and VEGF in esophageal carcinoma were significantly higher than those in normal esophageal tissue( P <0. 01). The expression level of VEGF was positively correlated with the expression of VASH1 in esophageal carcinoma,and the expression levels of VEGF and VASH1,depth of invasion and lymph node metastasis were the independent risk factors in influencing the prognosis of esophageal carcinoma( P < 0. 05 to P < 0. 01). The percentages of IPCL-Ⅴ and IPCL-Ⅳ were 54. 79% and 56. 82%,respectively,and the difference of which was not statistically significant( P > 0. 05). The differences of MVD value among the patients with negative,low and high VASH1 expressions were statistically significant( P < 0. 01). With the increasing of VASH1 expression level of patients,the MVD value increased,and the VASH1 expression was positively correlated with microvessel density( P < 0. 01).Conclusions: VASH1 may be closely related to the development of esophageal carcinoma and tumor cell formation,which has certain significance in predicting the prognosis of esophageal carcinoma.
作者 时军利 王磊 李萍 李炳庆 SHI Jun-li;WANG Lei;LI Ping;LI Bing-qing(Department of Gastroenterology,The Affiliated Hospital of Chengde Medical College,Chengde Hebei 067000,China)
出处 《蚌埠医学院学报》 CAS 2018年第12期1606-1609,共4页 Journal of Bengbu Medical College
基金 河北省承德市科学技术研究与发展计划项目(201601A028)
关键词 食管肿瘤 血管生成抑制蛋白1 肿瘤血管 内镜 esophagus neoplasms angiogenesis inhibitor 1 tumor vessel endoscopy
  • 相关文献

参考文献7

二级参考文献83

  • 1赵虹,张惊宇,徐万海,杨子超,赵庆杰.STUB1基因RNA干扰慢病毒载体的构建与鉴定[J].浙江大学学报(医学版),2010,39(6):623-627. 被引量:2
  • 2Weis SM,Cheresh DA. Tumor angiogenesis: molecular path- ways and therapeutic targets [ J ]. Nat Med, 2011,17 ( 11 ) : 1359.
  • 3Sato Y. The vasohibin family: a novel family for angiogen- esis regulation [ J ]. J Bioehem, 2013,153 ( 1 ) : 5.
  • 4Watanabe K,Hasegawa Y ,Yamashita H,et al. Vasohihin as an endothelium-derived negative feedback regulator of an- giogenesis [ J ]. J Clin Invest, 2004,114 ( 7 ) : 898.
  • 5Ahmed Z, Bieknell R. Angiogenic signalling pathways [ J ]. Methods Mol Biol,2009 ,467 :3.
  • 6Miyazaki Y, Kosaka T, Mikami S, et al. The prognostic sig- nificance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma [ J ]. Clin Cancer Res, 2012,18(15) :4145.
  • 7Kosaka T, Miyazaki Y, Miyajima A, et al. The prognostic significance of vasohibin-1 expression in patients with pros- tate cancer[J]. Br J Cancer,2013,108(10) :2123.
  • 8Tamaki K, Moriya T,Sato Y, et al. Vasohibin-1 in human breast carcinoma:a potential negative feedback regulator of angiogenesis [ J ]. Cancer Sci,2009,100 ( 1 ) : 88.
  • 9Shimizu K, Watanabe K, Yamashita H, et al. Gene regula- tion of a novel angiogenesis inhibitor, vasohibin, in endo- thelial cells [ J ]. Biochem Biophys Res Commun,2005,327 (3) :700.
  • 10Sato Y,Sonoda H. The vasohibin family: a negative regula- tory system of angiogenesis genetically programmed in en- dothelial cells [ J ]. Arterioscler Thromb Vase Biol,2007,27 (l) :37.

共引文献22

同被引文献37

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部